<DOC>
	<DOC>NCT02848807</DOC>
	<brief_summary>Determine whether nutritional support with high protein ONS in adult oncologic patients in the first step of cancer cachexia - asymptomatic precachexia, influence on the toxicity of systemic therapy.</brief_summary>
	<brief_title>Chemotherapy-related Toxicity, Nutritional Status and Quality of Life</brief_title>
	<detailed_description>Other endpoints: - to determine whether high protein ONS influence on the nutritional status - to determine whether high protein ONS influence on the quality of life - to determine whether high protein ONS influence on the performance status - to determine high protein ONS tolerability / ONS intake compliance</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<criteria>histological confirmed diagnosis of CRC in clinical stage IV successful qualification to chemotherapy performance status at least 80% according to Karnofsky scale and &lt;2 according to WHO/ECOG scale cancerrelated asymptomatic precachexia diagnosed absence of contraindications to oral nutrition and practicable realization of oral nutrition absence of severe, decompensated concomitant diseases signed informed consent for the participation in the study diagnosis of a malignant neoplasm in clinical stage IIII disqualification from oncologic treatment cancer cachexia or cancer anorexiacachexia syndrome poor performance status contraindications to oral nutrition or to high protein nutrition regular nutritional support at the moment of qualification to the study patient incompliance at the moment of qualification to the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>